Allarity Therapeutics Inc (NASDAQ:ALLR) price on Thursday, July 03, rose 1.00% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.01.
A look at the stock’s price movement, the close in the last trading session was $1.0, moving within a range at $0.9784 and $1.02. The beta value (5-Year monthly) was -0.154. Turning to its 52-week performance, $7.45 and $0.61 were the 52-week high and 52-week low respectively. Overall, ALLR moved 14.90% over the past month.
Allarity Therapeutics Inc’s market cap currently stands at around $15.23 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ALLR is a 50% Sell. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ALLR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ALLR’s current price about 9.79% and 2.47% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.83, while 7-day volatility ratio is 4.99% and 7.62% in the 30-day chart. Further, Allarity Therapeutics Inc (ALLR) has a beta value of 0.02.
If we refocus on Allarity Therapeutics Inc (NASDAQ:ALLR), historical trading data shows that trading volumes averaged 0.51 over the past 10 days and 799.01K over the past 3 months. The company’s latest data on shares outstanding shows there are 17.02 million shares.
The 23.57% of Allarity Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 0.61% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.65 million on 2025-06-13, giving us a short ratio of 1.25. The data shows that as of 2025-06-13 short interest in Allarity Therapeutics Inc (ALLR) stood at 432.0 of shares outstanding, with shares short falling to 1.24 million registered in 2025-05-15. Current price change has pushed the stock -85.14% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ALLR stock continues to rise going into the next quarter.
